Concourse Financial Group Securities’s Ascendis Pharma A/S ASND Stock Holding History

Concourse Financial Group Securities’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7	Closed	-$811	–	2166
2021 Q4	$1K	Sell	7 -364	-98%	-$54.1K	﹤0.01%	2265
2021 Q3	$59K	Sell	371 -58	-14%	-$7.94K	﹤0.01%	1237
2021 Q2	$56K	Buy	429 +12	+3%	+$1.6K	﹤0.01%	1253
2021 Q1	$54K	Buy	417 +72	+21%	+$10.9K	﹤0.01%	1192
2020 Q4	$58K	Buy	345 +65	+23%	+$10.7K	﹤0.01%	1102
2020 Q3	$43K	Buy	280 +113	+68%	+$16.2K	﹤0.01%	1113
2020 Q2	$25K	Buy	+167	New	+$22.9K	﹤0.01%	1213

Other funds holding ASND

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Concourse Financial Group Securities's ASND Position: Q1 2022 in Review

Concourse Financial Group Securities sold out of Ascendis Pharma A/S (ASND) in Q1 2022, closing a stake of 7 shares — an estimated $811 sold.

Concourse Financial Group Securities first reported a position in ASND in Q2 2020 and held it in 7 quarters. The position peaked at $59K in Q3 2021. 177 funds tracked by Wall St. Rank hold ASND as of Q1 2022.

Concourse Financial Group Securities reported no remaining Ascendis Pharma A/S position as of Q1 2022 after selling out during the quarter.
Concourse Financial Group Securities sold 7 Ascendis Pharma A/S shares in Q1 2022, an estimated $811.
Concourse Financial Group Securities first reported a position in Ascendis Pharma A/S in Q2 2020 and held it in 7 quarters.
Concourse Financial Group Securities's Ascendis Pharma A/S position peaked at $59K in Q3 2021.
177 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2022.

Based on Concourse Financial Group Securities's 13F filing for Q1 2022, filed 9 May 2022.